Led by CEO Dr Bernard Lee, we aim to be a one-stop service provider, covering the entire spectrum of pain care treatment solutions. We serve patients in Asia with our suite of services that include minimally invasive procedures, specialised injections, pharmacotherapy and cognitive behavioural therapy.
1. Could you describe Singapore Paincare Holdings’ (SPCH) business segments and its focus?
Singapore Paincare Holdings specialises in interventional pain management procedures for various pain conditions including acute and chronic pain due to injury, age-related pain conditions, functional pain disorders, post-surgical pain and cancer pain.
